Dosage of Yi Da in details
Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) is acid-stable and may be administered orally without regard to meals. Administration with food may be helpful in diminishing potential gastrointestinal complaints occasionally associated with oral cephalosporin therapy.
Adults
Urinary Tract Infections: For uncomplicated lower urinary tract infections (i.e., cystitis) the usual dosage is 1 or 2 g per day in single (q.d.) or divided doses (b.i.d).
For all other urinary tract infections the usual dosage is 2 g per day in divided doses (b.i.d).
Skin and Skin Structure Infections: For skin and skin structure infections the usual dosage is 1 g per day in single (q.d.) or divided doses (b.i.d).
Pharyngitis and Tonsillitis: Treatment of group A beta-hemolytic streptococcal pharyngitis and tonsillitis - 1 g per day in single (q.d.) or divided doses (b.i.d) for 10 days.
Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) oral suspension may be more suitable for pediatric patients
Children
For urinary tract infections, the recommended daily dosage for children is 30 mg/kg/day in divided doses every 12 hours. For pharyngitis, tonsillitis, and impetigo, the recommended daily dosage for children is 30 mg/kg/day in a single dose or in equally divided doses every 12 hours. For other skin and skin structure infections, the recommended daily dosage is 30 mg/kg/day in equally divided doses every 12 hours. In the treatment of beta-hemolytic streptococcal infections, a therapeutic dosage of Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) should be administered for at least 10 days.
Renal Impairment
In patients with renal impairment, the dosage of Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) should be adjusted according to creatinine clearance rates to prevent drug accumulation. The following schedule is suggested. In adults, the initial dose is 1000 mg of Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) and the maintenance dose (based on the creatinine clearance rate [mL/min/1.73 M]) is 500 mg at the time intervals listed below.
| Creatinine Clearances | Dosage Interval |
| 0 to 10 mL/min | 36 hours |
| 10 to 25 mL/min | 24 hours |
| 25 to 50 mL/min | 12 hours |
Patients with creatinine clearance rates over 50 mL/min may be treated as if they were patients having normal renal function
How supplied
Yi Da tablets contain Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) hemihydrate equivalent to 1 gram of Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) and are supplied as follows:
Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) 1 gram Tablets: white, oblong, biconvex film-coated tablets, debossed on one side with ‘CF 512’ and scored on the other side.
(50s) NDC 63304-512-50
(100s) NDC 63304-512-01
(unit-dose 100s) NDC 63304-512-80
Yi Da capsules contain Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) hemihydrate equivalent to 500 mg of Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) and are supplied as follows:
Yi Da (Yi Da (Yi Da hemihydrate) hemihydrate) 500 mg Capsules: white opaque body and brown opaque cap imprinted with ‘C’ on the cap and ‘582’ on the body.
(50s) NDC 63304-582-50
(100s) NDC 63304-582-01
Dispense in a tight container as defined in the USP.
Store at 20 - 25° C (68 - 77° F)..Manufactured for: Ranbaxy Pharmaceuticals Inc. Jacksonville, FL 32216 USA by: Ranbaxy Laboratories Ltd. New Delhi - 110 019, India March 2007
FDA rev date: 3/2007
What other drugs will affect Yi Da?
There may be other drugs that can interact with Yi Da. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start taking a new medication without telling your doctor.
Yi Da interactions
Positive direct Coombs' tests have been reported during treatment with the cephalosporin antibiotics. In hematologic studies or in transfusion cross-matching procedures when antiglobulin tests are performed on the minor side or in Coombs' testing of newborns whose mothers have received cephalosporin antibiotics before parturition, it should be recognized that a positive Coombs' test may be due to Yi Da.
References
- DailyMed. "CEFADROXIL/CEFADROXIL HEMIHYDRATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- FDA/SPL Indexing Data. "Q525PA8JJB: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
- MeSH. "Anti-Bacterial Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Yi Da are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Yi Da. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported frequency of use
No survey data has been collected yetConsumer reported doses
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
